A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
Manda S, Anz BM 3rd, Benton C, Broun ER, Yimer HA, Renshaw JS, Geils G Jr, Berdeja J, Cruz J, Melear JM, Fanning S, Fletcher L, Li Y, Duan Y, Werner ME, Potluri J, Pai MV, Donnellan WB.
Manda S, et al. Among authors: werner me.
Hematol Oncol. 2024 May;42(3):e3274. doi: 10.1002/hon.3274.
Hematol Oncol. 2024.
PMID: 38711253
Clinical Trial.